City of Hope offers outstanding medical treatment and psychosocial support to young leukemia or lymphoma patients and their family members.
Pediatric oncologists, hematologists, surgeons, radiation oncologists, pathologists and other specialists collaborate to develop a targeted, effective treatment plan.
Leukemia is a cancer of the blood and the most common cancer in children and teens, accounting for almost one out of three cancers.
At City of Hope, our team of pediatric experts provides comprehensive care for children with leukemia and lymphoma.
Adolescents and young adults may be eligible for clinical studies and novel treatments available for adult patients at City of Hope while still benefiting from the pediatric program's patient and family-centered approach.
When you come to City of Hope, you automatically gain access to an unparalleled array of support services to help you and your loved ones take each step during and after your leukemia or lymphoma treatment.
City of Hope has been named a best hospital for cancer by U.S. News & World Report for over a decade. Our program treats patients with a range of leukemias and lymphomas, including:
Leukemias
- Acute lymphoblastic leukemia (ALL)
- Acute myeloid leukemia (AML)
- Chronic myelogenous leukemia (CML)
Lymphomas
- Hodgkin lymphoma
- Non-Hodgkin lymphoma
- Anaplastic large-cell lymphoma (ALCL)
- B-cell lymphoma (Burkitt and Burkitt-like lymphoma)
- Diffuse large B-cell lymphoma (DLBC)
- Lymphoblastic lymphoma
- T-cell lymphoma
- MK-cell lymphoma
For more information, please visit our Department of Pediatrics website.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
